Skip to main content

Biopharma Startups

Updated October 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
906
Total Funding
$544.2M
Avg Funding
$21.8M
Global Reach
7
countries

Top Cities for Biopharma

Uruma
Jupiter
Oxford
San Diego
Houston
Cambridge

Recently Funded Companies

Export
Uruma, Japan

FullStem is a company specializing in high-density mass culture technology for stem cells.

Apr 2024

Founder Contacts

41,000+ verified contacts

Jupiter, United States

BioCurity Pharmaceuticals is a biopharmaceutical company developing drugs to prevent side effects of radiation therapy for cancer patients.

$75K raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Fermtech provides equipment for precision fermentation companies to scale production processes.

$3.3M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Oxeia Biopharmaceuticals is a clinical stage biotech company.

$1.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

$25.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Farmington Hills, United States

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

$35.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Bethesda, United States

Iyuda Therapeutics is a pharmaceutical therapeutics company developing treatments for oncological, infectious, and other immuno diseases.

$600K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Coquitlam, Canada

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

$3.0M raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.

Apr 2023

Founder Contacts

41,000+ verified contacts

London, United Kingdom

BioOrbit is a space manufacturing firm that develops hardware for large-scale protein drug crystallization.

$13.2M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Beverly, United States

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.

Apr 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.

$11.8M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Nantes, France

InFlectis BioScience is a private drug discovery company aiming at targeting.

$650K raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Dublin, Ireland

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

$117.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Santa Barbara, United States

Dimer Instruments designs and produces devices for real-time data monitoring and quality assurance in pharmaceutical manufacturing.

$6.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Austin, United States

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

$4.8M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Heverlee, Belgium

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

$125.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

London, Canada

Combilytics is a biotechnology company specializing in the creation of natural senolytic solutions that bolster anti-aging functions.

$250K raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Montréal, Canada

VVector Bio offers biomanufacturing services to accelerate the development and commercialization of novel medicines.

$250K raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

$25.0M raised
Apr 2022

Founder Contacts

41,000+ verified contacts

New York, United States

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

$47.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing.

$3.2M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

$16.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.

$4.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Showing 326 to 350 of 906 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.

Average Funding
$21.8M
Total Funding Tracked
$544.2M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Oxford
4 companies$10.5M
2.San Diego
2 companies$13.3M
3.London
2 companies$13.4M
4.Palo Alto
2 companies$41.5M
5.Uruma
1 companiesUndisclosed

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked